AAAAAA

   
Results: 1-8 |
Results: 8
IDENTIFICATION OF SIDE-CHAINS ON 1,2,5-THIADIAZOLE-AZACYCLES OPTIMAL FOR MUSCARINIC M1 RECEPTOR ACTIVATION
Authors: SAUERBERG P JEPPESEN L OLESEN PH SHEARDOWN MJ FINKJENSEN A RASMUSSEN T RIMVALL K SHANNON HE BYMASTER FP DELAPP NW CALLIGARO DO WARD JS WHITESITT CA THOMSEN C
Citation: P. Sauerberg et al., IDENTIFICATION OF SIDE-CHAINS ON 1,2,5-THIADIAZOLE-AZACYCLES OPTIMAL FOR MUSCARINIC M1 RECEPTOR ACTIVATION, Bioorganic & medicinal chemistry letters, 8(20), 1998, pp. 2897-2902
MUSCARINIC AGENTS - A NEW APPROACH TO THE TREATMENT OF PSYCHOSIS
Authors: SHANNON HE BYMASTER FP BODICK NW OFFEN WW DELAPP NC PERRY KW RASMUSSEN K WARD JS WHITESITT CA FINKJENSEN A OLESEN P RASMUSSEN T SHEARDOWN M SWEDBERG M SAUERBERG P
Citation: He. Shannon et al., MUSCARINIC AGENTS - A NEW APPROACH TO THE TREATMENT OF PSYCHOSIS, Schizophrenia research, 29(1-2), 1998, pp. 158-159
XANOMELINE COMPARED TO OTHER MUSCARINIC AGENTS ON STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IN-VIVO AND OTHER CHOLINOMIMETIC EFFECTS
Authors: BYMASTER FP CARTER PA PETERS SC ZHANG W WARD JS MITCH CH CALLIGARO DO WHITESITT CA DELAPP N SHANNON HE RIMVALL K JEPPESEN L SHEARDOWN MJ FINKJENSEN A SAUERBERG P
Citation: Fp. Bymaster et al., XANOMELINE COMPARED TO OTHER MUSCARINIC AGENTS ON STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IN-VIVO AND OTHER CHOLINOMIMETIC EFFECTS, Brain research, 795(1-2), 1998, pp. 179-190
XANOMELINE - A SELECTIVE MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE
Authors: BYMASTER FP WHITESITT CA SHANNON HE DELAPP N WARD JS CALLIGARO DO SHIPLEY LA BUELKESAM JL BODICK NC FARDE L SHEARDOWN MJ OLESEN PH HANSEN KT SUZDAK PD SWEDBERG MDB SAUERBERG P MITCH CH
Citation: Fp. Bymaster et al., XANOMELINE - A SELECTIVE MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE, Drug development research, 40(2), 1997, pp. 158-170
IN-VIVO PHARMACOLOGY OF BUTYLTHIO[2.2.2] (LY297802 NNC11-1053), AN ORALLY ACTING ANTINOCICEPTIVE MUSCARINIC AGONIST/
Authors: SHANNON HE WOMER DE BYMASTER FP CALLIGARO DO DELAPP NC MITCH CH WARD JS WHITESITT CA SWEDBERG MDB SHEARDOWN MJ FINKJENSEN A OLESEN PH RIMVALL K SAUERBERG P
Citation: He. Shannon et al., IN-VIVO PHARMACOLOGY OF BUTYLTHIO[2.2.2] (LY297802 NNC11-1053), AN ORALLY ACTING ANTINOCICEPTIVE MUSCARINIC AGONIST/, Life sciences, 60(13-14), 1997, pp. 969-976
SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF BENZOPHENONES AS INHIBITORS OF CATHEPSIN-D
Authors: WHITESITT CA SIMON RL REEL JK SIGMUND SK PHILLIPS ML SHADLE JK HEINZ LJ KOPPEL GA HUNDEN DC LIFER SL BERRY D RAY J LITTLE SP LIU XD MARSHALL WS PANETTA JA
Citation: Ca. Whitesitt et al., SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF BENZOPHENONES AS INHIBITORS OF CATHEPSIN-D, Bioorganic & medicinal chemistry letters, 6(18), 1996, pp. 2157-2162
CHIRAL RECOGNITION OF THE ANGIOTENSIN-II (AT(1)) RECEPTOR BY A HIGHLYPOTENT PHENOXYPROLINE OCTANOAMIDE
Authors: STEINBERG MI PALKOWITZ AD THRASHER KJ REEL JK ZIMMERMAN KM WHITESITT CA SIMON RL HAUSER KL LIFER SL PFEIFER W TAKEUCHI K WIEST SA VASUDEVAN V BEMIS KG DEETER JB BARNETT CJ WILSON TM MARSHALL WS BOYD DB
Citation: Mi. Steinberg et al., CHIRAL RECOGNITION OF THE ANGIOTENSIN-II (AT(1)) RECEPTOR BY A HIGHLYPOTENT PHENOXYPROLINE OCTANOAMIDE, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 51-56
STRUCTURAL EVOLUTION AND PHARMACOLOGY OF A NOVEL SERIES OF TRIACID ANGIOTENSIN-II RECEPTOR ANTAGONISTS
Authors: PALKOWITZ AD STEINBERG MI THRASHER KJ REEL JK HAUSER KL ZIMMERMAN KM WIEST SA WHITESITT CA SIMON RL PFEIFER W LIFER SL BOYD DB BARNETT CJ WILSON TM DEETER JB TAKEUCHI K RILEY RE MILLER WD MARSHALL WS
Citation: Ad. Palkowitz et al., STRUCTURAL EVOLUTION AND PHARMACOLOGY OF A NOVEL SERIES OF TRIACID ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 37(26), 1994, pp. 4508-4521
Risultati: 1-8 |